Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study

Clinical trials revealed significant antitumor activity for immune checkpoint inhibitors (ICI) in metastatic urothelial carcinoma (mUC). Due to their strict eligibility criteria, clinical trials include selected patient cohorts, and thus do not necessarily represent real-world population outcomes. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Váradi, Melinda, Horváth, Orsolya, Módos, Orsolya, Fazekas, Tamás, Grunewald, Camilla M., Niegisch, Günter, Krafft, Ulrich, Grünwald, Viktor, Hadaschik, Boris, Olah, Csilla, Maráz, Anikó, Furka, Andrea, Szűcs, Miklós, Nyirády, Péter, Szarvas, Tibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575904/
https://www.ncbi.nlm.nih.gov/pubmed/37833455
http://dx.doi.org/10.1038/s41598-023-44103-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575904/
https://www.ncbi.nlm.nih.gov/pubmed/37833455
http://dx.doi.org/10.1038/s41598-023-44103-9

Ejemplares similares